2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by KLIGER, A. S. Articles by HALEY, W. E. Search for Related Content PubMed PubMed Citation Articles by KLIGER, A. S. Articles by HALEY, W. E.

Clinical Practice Guidelines in End-Stage Renal Disease

A Strategyfor Implementation

ALAN S. KLIGER^* and WILLIAM E. HALEY

^* Yale University School of Medicine, New Haven, Connecticut
Mayo Clinic, Jacksonville, Florida

Correspondence to Dr. Alan S. Kliger, New Haven CAPD, 136 Sherman Avenue, New Haven, CT 06510. Phone: 203-773-0853; Fax: 203-776-2904; E-mail: AKliger{at}compuserv.com

Abstract

Abstract. Clinical practice guidelines (CPGs) for end-stage renal failure (ESRD) were recently published, and represent a comprehensive review of available literature and the considered judgment of experts in ESRD. To prioritize and implement these guidelines, the evidence underlying each guideline should be ranked and the attributes of each should be defined. Strategies to improve practice patterns should be tested. Focused information for each high priority guideline should be disseminated, including a synopsis and assessment of the underlying evidence, the evidence model used to develop that guideline, and suggested strategies for CPG implementation. Clinical performance measures should be developed and used to measure current practice, and the success of changing practice patterns on clinical outcomes. Individual practitioners and dialysis facilities should be encouraged to utilize continuous quality improvement techniques to put the guidelines into effect. Local implementation should proceed at the same time as a national project to convert high priority CPGs into clinical performance measures proceeds. Patients and patient care organizations should participate in this process, and professional organizations must make a strong commitment to educate clinicians in the methodology of CPG and performance measure development and the techniques of continuous quality improvement. Health care regulators should understand that CPGs are not standards, but are statements that assist practitioners and patients in making decisions.

This article has been cited by other articles:

				C. Couchoud, K. J. Jager, C. Tomson, J.-F. Cabanne, F. Collart, P. Finne, A. de Francisco, L. Frimat, L. Garneata, T. Leivestad, et al. Assessment of urea removal in haemodialysis and the impact of the European best practice guidelines Nephrol. Dial. Transplant., November 27, 2008; (2008) gfn641v1. [Abstract] [Full Text] [PDF]

				M. B. Patwardhan, D. B. Matchar, G. P. Samsa, and W. E. Haley Opportunities for Improving Management of Advanced Chronic Kidney Disease American Journal of Medical Quality, June 1, 2008; 23(3): 184 - 192. [Abstract] [PDF]

				F. Locatelli, S. Andrulli, and L. Del Vecchio Difficulties of implementing clinical guidelines in medical practice Nephrol. Dial. Transplant., September 1, 2000; 15(9): 1284 - 1287. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673